Adragos Pharma is an internationally operating contract development and manufacturing organization headquartered in Germany. As a reliable partner, the company offers comprehensive services for drug products across small and large molecules, including end-to-end production of small molecule finished dosage forms - sterile and non-sterile liquids, solids, and semi solids - as well as fill and finish of biologics in glass vials and pre-filled syringes. Adragos currently operates six production sites in France, Germany, Norway, Switzerland, and Japan, and a development site in Greece.
| Website | https://www.adragos-pharma.com/ |
| Revenue | $21.5 million |
| Employees | 368 (205 on RocketReach) |
| Founded | 2020 |
| Address | Sonnenstraße 17, Munich, Bavaria 80331, DE |
| Technologies |
JavaScript
,
HTML
,
Twitter
+8 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing |
| Competitors | Johnson & Johnson, Roche, Novartis, AbbVie, Merck & Co., Inc., Sanofi, AstraZeneca, Bristol Myers Squibb, Gilead Sciences, Pfizer +44 more (view full list) |
Looking for a particular Adragos Pharma employee's phone or email?
The Adragos Pharma annual revenue was $21.5 million in 2026.
Konstantinos Rengis is the CEO of Adragos Pharma.
205 people are employed at Adragos Pharma.
Adragos Pharma is based in Munich, Bavaria.